AKT2 and lung carcinoma: In consequence, AKT2 showed obviously declining upon miR-29c overexpression comparing to negative control mimic transfection in both mRNA level and protein level in the two cell lines, indicating AKT2 is also a direct target of miR-29c in lung cancer (Fig. 4B).